TT virus in hematological disorders and bone marrow transplant recipients

Leukemia and Lymphoma

Volumn 40, Issue 5-6, 2001, Pages 483-489

  Kanda, Y ^a   Hirai, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone marrow transplant; Hematology; Recipients; TT virus

Indexed keywords

BIODIVERSITY; BLOOD DISEASE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CIRCOVIRIDAE; CLONE; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; GENOTYPE; HEMATOPOIETIC CELL; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HEPATITIS G; HEPATITIS NON A NON B; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER INJURY; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; REVIEW; SEQUENCE ANALYSIS; TORQUE TENO VIRUS; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0035044701     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097647     Document Type: Review

References (52)

1. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC)
2. Cryptogenic liver disease in the United States: Further evidence for non-A, non-B, and non-C hepatitis
3. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis
4. Etiology of fulminant hepatic failure: Is another virus involved?
5. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent
6. Isolation of novel virus-like sequences associated with human hepatitis
7. Infection with hepatitis GB virus C in patients on maintenance hemodialysis
8. Molecular evidence for transmission of hepatitis G virus by blood transfusion
9. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection
10. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
11. Hepatitis G virus - A true hepatitis virus or an accidental tourist?
12. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology
13. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology
14. Molecular and biophysical characterization of TT virus: Evidence for a new virus family infecting humans
15. Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circocirus
16. The entire nucleotide sequence of a TT virus isolate from the United States (TUS01): Comparison with reported isolates and phylogenetic analysis
17. Detection of a novel DNA virus (TTV) in blood donors and blood products
18. New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism
19. A novel unenveloped DNA virus (TT virus) associated with acute and chronic non-A to G hepatitis
20. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions
21. TT virus in bone marrow transplant recipients
22. Presence of a newly described human DNA virus (TTV) in patients with liver disease
23. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis
24. A new genotype of TT virus (TTV) infection among Colombian native Indians
25. A prospective study on TT virus infection in transfusion-dependent patients with beta-thalassemia
26. Infection with an unenveloped DNA virus (TTV) associated with posttransfusion non-A to G hepatitis in hepatitis patients and healthy blood donors in Thailand
27. High prevalence of TT virus infection in Brazilian blood donors
28. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers
29. Frequency of TTV viraemia in Japanese population by age
30. Age-specific prevalence and transmission of TT virus
31. TT virus in frequently transfused patients
32. Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese haemophiliacs
33. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis
34. Excretion into bile of a novel unenveloped DNA virus (TT virus) associated with acute and chronic non-A-G hepatitis
35. Transmission of and liver injury by TT virus in patients on maintenance hemodialysis
36. TT virus infection in French hemodialysis patients: Study of prevalence and risk factors
37. Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients
38. High prevalence of TT virus (TTV) infection in patients on maintenance hemodialysis: Frequent mixed infections with different genotypes and lack of evidence of associated liver disease
39. Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-A to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells
40. Transfusion transmitted virus
41. Infection by an unenveloped DNA virus associated with non-A to G hepatitis in Japanese blood donors with or without elevated ALT levels
42. Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line
43. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma
44. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell
45. Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration
46. Multiple infection of TT virus (TTV) with different genotypes in Japanese hemophiliacs
47. Fulminant hepatitis due to reactivation of chronic hepatitis B infection after allogeneic bone marrow transplantation
48. Fulminant hepatitis is significantly increased in hepatitis B carriers after allogeneic bone marrow transplantation
49. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: A case controlled study
50. Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management
51. Quantitation of hepatitis G virus RNA in bone marrow transplant recipients
52. Presence of TT virus in French blood donors and intravenous drug users